MX2019009761A - Composicion antiseptica que comprende polivinilpirrolidona y unitiol y uso de la composicion. - Google Patents

Composicion antiseptica que comprende polivinilpirrolidona y unitiol y uso de la composicion.

Info

Publication number
MX2019009761A
MX2019009761A MX2019009761A MX2019009761A MX2019009761A MX 2019009761 A MX2019009761 A MX 2019009761A MX 2019009761 A MX2019009761 A MX 2019009761A MX 2019009761 A MX2019009761 A MX 2019009761A MX 2019009761 A MX2019009761 A MX 2019009761A
Authority
MX
Mexico
Prior art keywords
composition
antiseptic
unithiol
compositions according
polyvinylpyrrolidone
Prior art date
Application number
MX2019009761A
Other languages
English (en)
Inventor
Gennadievna Afinogenova Anna
Evgenievich AFINOGENOV Gennady
Omarovich Manasherov Tamaz
Konstantinovna Matelo Svetlana
Original Assignee
Medid Innovation Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medid Innovation Dev Ltd filed Critical Medid Innovation Dev Ltd
Publication of MX2019009761A publication Critical patent/MX2019009761A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents

Abstract

La invención se refiere a nuevas composiciones antisépticas basadas en polímeros para el tratamiento de heridas y/o para uso en operaciones quirúrgicas, que forman una película en la superficie de la herida y tienen efectos antisépticos, anestésicos y antitóxicos. Las composiciones de acuerdo con la invención comprenden polivinilpirrolidona con un peso molecular promedio en peso en el intervalo de 1.000.000 a 3.000.000 Da, uno o más antisépticos, unitiol, dimetilsulfóxido y uno o más anestésicos, preferentemente anestésicos locales. Además, la presente invención se refiere al uso de las composiciones de acuerdo con la invención en un tratamiento de heridas, así como los métodos para tratar heridas usando las composiciones de acuerdo con la invención que comprenden la etapa de aplicar la composición de acuerdo con la invención a una superficie de herida.
MX2019009761A 2017-02-22 2017-12-14 Composicion antiseptica que comprende polivinilpirrolidona y unitiol y uso de la composicion. MX2019009761A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2017106061A RU2649785C1 (ru) 2017-02-22 2017-02-22 Антисептическая композиция, содержащая поливинилпирролидон и унитиол, применение такой композиции и способ обработки ран с ее использованием
PCT/RU2017/000905 WO2018156051A1 (en) 2017-02-22 2017-12-14 Antiseptic composition comprising polyvinylpyrrolidone and unithiol and use of the composition

Publications (1)

Publication Number Publication Date
MX2019009761A true MX2019009761A (es) 2019-10-07

Family

ID=61094570

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019009761A MX2019009761A (es) 2017-02-22 2017-12-14 Composicion antiseptica que comprende polivinilpirrolidona y unitiol y uso de la composicion.

Country Status (19)

Country Link
US (1) US11045551B2 (es)
EP (1) EP3585399B1 (es)
JP (1) JP6690816B2 (es)
KR (1) KR102096257B1 (es)
CN (1) CN110198721B (es)
AU (1) AU2017400650B2 (es)
BR (1) BR112019016560A2 (es)
CA (1) CA3054002C (es)
CL (1) CL2019002259A1 (es)
EA (1) EA037319B1 (es)
GE (1) GEP20207136B (es)
MA (1) MA46159B1 (es)
MX (1) MX2019009761A (es)
PL (1) PL3585399T3 (es)
RU (1) RU2649785C1 (es)
SG (1) SG11201903097UA (es)
UA (1) UA121949C2 (es)
WO (1) WO2018156051A1 (es)
ZA (1) ZA201905343B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2713884C1 (ru) * 2018-12-18 2020-02-10 Екатерина Николаевна Мехоношина Жидкая композиция для получения спрея для формирования антимикробной раневой повязки при микротравмах кожи

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2739922A (en) 1952-03-13 1956-03-27 Herman A Shelanski Mixtures of polymeric n-vinyl pyrrolidone and halogens
US3761590A (en) 1970-05-18 1973-09-25 Research Corp Silver sulfadiazine used in the treatment of burns
GB2148901A (en) 1983-10-04 1985-06-05 Johnson & Johnson Protein/polysaccharide complexes
RU2062113C1 (ru) * 1993-10-19 1996-06-20 Владимир Валентинович Рыльцев Способ получения перевязочных материалов
RU2088234C1 (ru) 1994-11-25 1997-08-27 Институт высокомолекулярных соединений РАН Водорастворимая бактерицидная композиция и способ ее получения
UA13954C2 (uk) * 1996-06-13 2001-05-15 Державний Науковий Центр Лікарських Засобів Аhтибактеріальhий засіб для місцевого застосуваhhя
RU2185155C2 (ru) 2000-04-27 2002-07-20 Кривошеин Юрий Семенович Клей антисептический ранозаживляющий
US6828308B2 (en) * 2000-07-28 2004-12-07 Sinclair Pharmaceuticals, Ltd. Compositions and methods for the treatment or prevention of inflammation
RU2175549C1 (ru) * 2000-10-26 2001-11-10 Закрытое акционерное общество "ТОП-ВЕТ" Ранозаживляющий лекарственный препарат "зоодерм"
US10117812B2 (en) * 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
RU2284824C1 (ru) * 2005-03-18 2006-10-10 Общество с ограниченной ответственностью "Сирена" Клей хирургический антисептический "аргакол"
WO2006121219A1 (ja) * 2005-05-13 2006-11-16 Osaka University 上皮−間葉転換制御剤
BRPI0716270A2 (pt) * 2006-08-28 2013-08-13 Rexaderm Inc bandagem de ferida seca e sistema de distribuiÇço de fÁrmaco
RU2403921C1 (ru) * 2009-04-01 2010-11-20 Государственное образовательное учреждение высшего профессионального образования "Дальневосточный государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" Способ комбинированного лечения ограниченной склеродермии с применением локального трансдермального ферментативного электростатического воздействия
RU2404781C1 (ru) * 2009-07-23 2010-11-27 Институт элементоорганических соединений РАН (ИНЭОС РАН) Композиция в качестве бактерицидного средства, способ получения материала на ее основе и макропористый бактерицидный материал на основе данной композиции
CN103505470A (zh) * 2012-06-22 2014-01-15 江苏胜意药业有限公司 一种聚维酮碘溶液的生产方法
EP3698793A1 (en) * 2014-01-29 2020-08-26 Vyome Therapeutics Limited Besifloxacin for the treatment of resistant acne
RU2545915C1 (ru) * 2014-02-14 2015-04-10 Олег Васильевич Рубальский Способ лечения хронического болевого синдрома
RU2545798C1 (ru) * 2014-03-24 2015-04-10 Закрытое акционерное общество "ФИРН М" (ЗАО "ФИРН М") Фармацевтическая композиция для оказания первой медицинской помощи при ожогах различной этиологии, площади и глубины в форме спрея, геля, аэрозоля
RU2603490C1 (ru) * 2015-11-30 2016-11-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Средство для лечения гнойно-воспалительных процессов мягких тканей и слизистых оболочек
RU2605343C1 (ru) * 2015-11-30 2016-12-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Средство для лечения гнойно-воспалительных процессов мягких тканей и слизистых оболочек

Also Published As

Publication number Publication date
MA46159A1 (fr) 2021-04-30
CN110198721A (zh) 2019-09-03
AU2017400650B2 (en) 2019-09-26
US11045551B2 (en) 2021-06-29
PL3585399T3 (pl) 2022-05-30
RU2649785C1 (ru) 2018-04-04
CN110198721B (zh) 2022-06-07
EP3585399B1 (en) 2022-02-09
EA037319B1 (ru) 2021-03-11
KR102096257B1 (ko) 2020-04-06
MA46159B1 (fr) 2022-04-29
UA121949C2 (uk) 2020-08-10
SG11201903097UA (en) 2019-09-27
ZA201905343B (en) 2021-08-25
KR20190099338A (ko) 2019-08-26
GEP20207136B (en) 2020-07-27
JP6690816B2 (ja) 2020-04-28
EA201991275A1 (ru) 2019-11-29
BR112019016560A2 (pt) 2020-03-31
EP3585399A1 (en) 2020-01-01
CA3054002C (en) 2021-07-20
AU2017400650A1 (en) 2019-07-18
US20190381176A1 (en) 2019-12-19
JP2020506164A (ja) 2020-02-27
WO2018156051A1 (en) 2018-08-30
CL2019002259A1 (es) 2020-01-03
CA3054002A1 (en) 2018-08-30

Similar Documents

Publication Publication Date Title
MX2020010405A (es) Composicion para el tratamiento de heridas cronicas.
NZ755166A (en) Biofilm disrupting composition for use on chronic wounds
ATE368380T1 (de) Neue antiseptische derivate mit breitem antimikrobiellem wirkungsspektrum zur imprägnierung von oberflächen
MX2020001403A (es) Nuevos derivados de quinolina.
MX2017006968A (es) Desinfectante de superficies con propiedad biocida residual.
NZ713621A (en) Compounds and methods of treating infections
BR112016021034A8 (pt) composição farmacêutica, uso da mesma e kit
WO2019169333A8 (en) Afibrotic compounds, devices, and uses thereof
WO2015002932A8 (en) Antimicrobial compositions comprising hypochlorous acid and silver
RU2020123728A (ru) Композиции гиалуроновой кислоты с высокоэластичными свойствами и способы их применения
MX2022007285A (es) Compuestos, polimeros, dispositivos y usos de los mismos.
PH12019501469A1 (en) Compositions and methods for treating biofilms
BR112017006406A2 (pt) composições e métodos para o tratamento e profilaxia de infecções de sítio cirúrgico
EP4272832A3 (en) Antimicrobial compounds, compositions, and uses thereof
MX2021001612A (es) Compuestos utiles en terapia del vih.
MX2021004755A (es) Uso de plasma y fracciones de plasma para mejorar el dolor, la cicatrizacion de heridas y la recuperacion posoperatoria.
WO2015066302A3 (en) Compositions, methods of use, and methods of treatment
MX2019009761A (es) Composicion antiseptica que comprende polivinilpirrolidona y unitiol y uso de la composicion.
WO2018094023A3 (en) Cyclic dipeptides and wound healing
AU2017394032A8 (en) Use of paeoniflorin-6'-o-benzenesulfonate in treatment of sjögren's syndrome
ZA202004002B (en) Pharmaceutical composition
WO2014117010A3 (en) Composition for ophthalmic administration
CA3054005C (en) Antiseptic composition comprising unithiol and dimethylsulfoxide, use of the composition and method of wound treatment with its use
IN2013MU02532A (es)
PH12021551010A1 (en) Compositions for treating biofilms without inducing antimicrobial resistance